Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Resources
Press Release, 9 August 2023
Adhoc Press Release
Kuros Biosciences Reports Results for First Half 2023
Press Release, 13 July 2023
Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
Press Release, 8 May 2023
Adhoc Press Release
Annual General Meeting of Kuros Biosciences approves all resolutions
Press Release, 27 April 2023
Adhoc Press Release
Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023
Press Release, 15 March 2023
Adhoc Press Release
Kuros Biosciences reports results for the full year 2022
Press Release, 21 February 2023
Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft
press-releases
2023